Berkshire Hathaway (BRK-B)

Outperform Current rating · 4 reports

2026-05-05

Outperform Recap: Q1 2026

Maintaining Outperform: The Buyback Resumes for the First Time Since 2024, Cash Still Hits a Record $397B After OxyChem, and Abel's First Annual Meeting Stresses Continuity

2026-03-03

Outperform Recap: Q4 2025

Upgrading to Outperform into the Sell-Off: A Cyclically Weak Quarter Masks a 12-Point Relative De-Rating, Abel's First Letter Reopens the Buyback Door, and OxyChem Closes

2025-11-04

Hold Recap: Q3 2025

Maintaining Hold: A 34% Operating-Earnings Jump That's Mostly FX and an Easy Catastrophe Comp — Meanwhile Cash Hits a Record $382B and the First Deal in Years Barely Dents It

2025-08-05

Hold Recap: Q2 2025

Initiating Berkshire at Hold: The Operating Engine Compounds Fine — It's the $344B of Idle Cash, the Buyback Drought, and the Succession Clock That Keep Us Neutral